JP2017533937A - オキソルペン誘導体 - Google Patents
オキソルペン誘導体 Download PDFInfo
- Publication number
- JP2017533937A JP2017533937A JP2017525933A JP2017525933A JP2017533937A JP 2017533937 A JP2017533937 A JP 2017533937A JP 2017525933 A JP2017525933 A JP 2017525933A JP 2017525933 A JP2017525933 A JP 2017525933A JP 2017533937 A JP2017533937 A JP 2017533937A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- substituted
- mmol
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC(C)C1=C([C@@](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@]2[C@]2(C)[C@]4C(C)(C)C(**)=CC2)[C@]3(C=C=C[U])C=C1c1ccccc1 Chemical compound CC(C)C1=C([C@@](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@]2[C@]2(C)[C@]4C(C)(C)C(**)=CC2)[C@]3(C=C=C[U])C=C1c1ccccc1 0.000 description 4
- HUBKYQGHTCOOGJ-WTBHOJAXSA-N CC(C)C(C(C1)=O)=C([C@@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)C2[C@]2(C)C4C(C)(C)C(C(CC4)=CC[C@]4(CF)C(O)=O)=CC2)[C@]13C=O Chemical compound CC(C)C(C(C1)=O)=C([C@@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)C2[C@]2(C)C4C(C)(C)C(C(CC4)=CC[C@]4(CF)C(O)=O)=CC2)[C@]13C=O HUBKYQGHTCOOGJ-WTBHOJAXSA-N 0.000 description 1
- QBEGKYFFANXUFQ-URLGSAGUSA-N CC(C)C(C(C1)=O)=C([C@@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@H]2[C@@](C)(CC2)C4C(C)(C)[C@H]2OC(C)=O)[C@]13NC(OC(C)(C)C)=O Chemical compound CC(C)C(C(C1)=O)=C([C@@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@H]2[C@@](C)(CC2)C4C(C)(C)[C@H]2OC(C)=O)[C@]13NC(OC(C)(C)C)=O QBEGKYFFANXUFQ-URLGSAGUSA-N 0.000 description 1
- RBNATQNVXVWQNG-LEKIWYMHSA-N CC(C)C(C(C1)=O)=C([C@@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@H]2[C@@](C)(CC2)[C@@H]4C(C)(C)[C@H]2OC(C)=O)[C@]13C(O)=O Chemical compound CC(C)C(C(C1)=O)=C([C@@H](CC2)[C@@](C)(CC3)[C@](C)(CC4)[C@H]2[C@@](C)(CC2)[C@@H]4C(C)(C)[C@H]2OC(C)=O)[C@]13C(O)=O RBNATQNVXVWQNG-LEKIWYMHSA-N 0.000 description 1
- YGEYQNIJJDMRPL-VNTGHVHSSA-N CC(C)C(C(C1)=O)=C([C@H]2CC3)[C@@]1(CO)CC[C@@]2(C)[C@](C)(CC1)[C@H]3[C@@](C)(CC2)[C@@H]1C(C)(C)[C@H]2O Chemical compound CC(C)C(C(C1)=O)=C([C@H]2CC3)[C@@]1(CO)CC[C@@]2(C)[C@](C)(CC1)[C@H]3[C@@](C)(CC2)[C@@H]1C(C)(C)[C@H]2O YGEYQNIJJDMRPL-VNTGHVHSSA-N 0.000 description 1
- VWZYBOGUWGGDEC-JTRCZKRUSA-N CC(C)C(C(C1)=O)=C([C@H]2CC3)[C@@]1(CO)CC[C@@]2(C)[C@](C)(CC1)[C@H]3[C@@](C)(CC=C(C2(C)C)C(CC3)=CC[C@]3(CF)C(O)=O)C12O Chemical compound CC(C)C(C(C1)=O)=C([C@H]2CC3)[C@@]1(CO)CC[C@@]2(C)[C@](C)(CC1)[C@H]3[C@@](C)(CC=C(C2(C)C)C(CC3)=CC[C@]3(CF)C(O)=O)C12O VWZYBOGUWGGDEC-JTRCZKRUSA-N 0.000 description 1
- ZKVXQDWHRXJZGK-XUZHXVEESA-N CC(C)C(C(C1)=O)=C([C@H]2CC3)[C@@]1(COC(C)=O)CC[C@@]2(C)[C@](C)(CC1)[C@H]3[C@@](C)(CC2)[C@@H]1C(C)(C)[C@H]2OC(C)=O Chemical compound CC(C)C(C(C1)=O)=C([C@H]2CC3)[C@@]1(COC(C)=O)CC[C@@]2(C)[C@](C)(CC1)[C@H]3[C@@](C)(CC2)[C@@H]1C(C)(C)[C@H]2OC(C)=O ZKVXQDWHRXJZGK-XUZHXVEESA-N 0.000 description 1
- LMTTZNAZSLOOOK-UCMQSTDXSA-N CC(C)C(C(C1)=O)=C([C@H]2CC3)[C@@]1(COC(c1ccccc1)=O)CC[C@@]2(C)[C@](C)(CC1)[C@H]3[C@@](C)(CC2)[C@@H]1C(C)(C)C2=O Chemical compound CC(C)C(C(C1)=O)=C([C@H]2CC3)[C@@]1(COC(c1ccccc1)=O)CC[C@@]2(C)[C@](C)(CC1)[C@H]3[C@@](C)(CC2)[C@@H]1C(C)(C)C2=O LMTTZNAZSLOOOK-UCMQSTDXSA-N 0.000 description 1
- VTMWAQPRYDEGRP-NRFANRHFSA-N CC1(C)OB(C(CC2)=CC[C@]2(CF)C(OCc2ccccc2)=O)OC1(C)C Chemical compound CC1(C)OB(C(CC2)=CC[C@]2(CF)C(OCc2ccccc2)=O)OC1(C)C VTMWAQPRYDEGRP-NRFANRHFSA-N 0.000 description 1
- ZREZDODZGZVRBD-UHFFFAOYSA-N CCOC(C1CC=C(B2OC(C)(C)C(C)(C)O2)CC1)=O Chemical compound CCOC(C1CC=C(B2OC(C)(C)C(C)(C)O2)CC1)=O ZREZDODZGZVRBD-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N Cc1ncccc1 Chemical compound Cc1ncccc1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- FSRMWCVZAUEPEQ-UHFFFAOYSA-N NCCCN(CC1)CCS1(=O)=O Chemical compound NCCCN(CC1)CCS1(=O)=O FSRMWCVZAUEPEQ-UHFFFAOYSA-N 0.000 description 1
- CHIHQLCVLOXUJW-UHFFFAOYSA-N O=C(c1ccccc1)OC(c1ccccc1)=O Chemical compound O=C(c1ccccc1)OC(c1ccccc1)=O CHIHQLCVLOXUJW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462079977P | 2014-11-14 | 2014-11-14 | |
| US62/079,977 | 2014-11-14 | ||
| PCT/US2015/060344 WO2016077561A1 (en) | 2014-11-14 | 2015-11-12 | Oxolupene derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017533937A true JP2017533937A (ja) | 2017-11-16 |
| JP2017533937A5 JP2017533937A5 (enExample) | 2018-11-01 |
Family
ID=54697682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017525933A Pending JP2017533937A (ja) | 2014-11-14 | 2015-11-12 | オキソルペン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9969767B2 (enExample) |
| EP (1) | EP3218387A1 (enExample) |
| JP (1) | JP2017533937A (enExample) |
| KR (1) | KR20170087478A (enExample) |
| CN (1) | CN107250153A (enExample) |
| AU (1) | AU2015346303B2 (enExample) |
| BR (1) | BR112017009850A2 (enExample) |
| CA (1) | CA2967679A1 (enExample) |
| RU (1) | RU2017118489A (enExample) |
| WO (1) | WO2016077561A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017017609A1 (en) * | 2015-07-28 | 2017-02-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Betuin derivatives for preventing or treating hiv infections |
| CA2993758A1 (en) * | 2015-07-28 | 2017-02-02 | Glaxosmithkline Intellectual Property (No.2) Limited | Betuin derivatives for preventing or treating hiv infections |
| AU2016327169A1 (en) * | 2015-09-24 | 2018-04-12 | Glaxosmithkline Intellectual Property (No.2) Limited | Compounds with hiv maturation inhibitory activity |
| EP3405474A1 (en) * | 2016-01-20 | 2018-11-28 | Glaxosmithkline Intellectual Property (No. 2) Limited | Amine derivatives of lupanes with hiv maturation inhibitory activity |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011508748A (ja) * | 2008-01-03 | 2011-03-17 | バイロケム ファーマ インコーポレイテッド | 新規のルパン誘導体 |
| WO2011153315A1 (en) * | 2010-06-04 | 2011-12-08 | Bristol-Myers Squibb Company | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| WO2011153319A1 (en) * | 2010-06-04 | 2011-12-08 | Bristol-Myers Squibb Company | C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| WO2013117137A1 (en) * | 2012-02-08 | 2013-08-15 | Jiangxi Qingfeng Pharmaceutical Inc. | Lupane triterpenoid derivatives and pharmaceutical use thereof |
| WO2013123019A1 (en) * | 2012-02-15 | 2013-08-22 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with hiv maturation inhibitory activity |
| JP2014507422A (ja) * | 2011-01-31 | 2014-03-27 | ブリストル−マイヤーズ スクイブ カンパニー | Ｈｉｖ成熟阻害剤としてのｃ−３修飾ベツリン酸誘導体のｃ−２８アミン |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| US5679828A (en) | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US7365221B2 (en) | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| MXPA06010592A (es) | 2004-03-17 | 2007-06-12 | Panacos Pharmaceuticals Inc | Sales farmaceuticas de acido 3-o-(3',3'-dimetilsuccinil) betulinico. |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| US20110144069A1 (en) | 2006-10-16 | 2011-06-16 | Myriad Genetics, Incorporated | Compounds for treating viral infections |
| AR063546A1 (es) * | 2006-11-03 | 2009-01-28 | Panacos Pharmaceuticals Inc | DERIVADOS DE TRITERPENO, METODOS PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN Y SU USO EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIoN POR EL VIRUS VIH. |
| US8269026B2 (en) * | 2008-01-03 | 2012-09-18 | Vertex Pharmaceuticals Incorporated | Lupane derivatives useful for treating HIV |
| EP2257567A1 (en) | 2008-02-14 | 2010-12-08 | Virochem Pharma Inc. | Novel 17 beta lupane derivatives |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| EA201290632A1 (ru) * | 2010-02-11 | 2013-03-29 | ГЛАКСОСМИТКЛАЙН ЭлЭлСи | Производные бетулина |
| US8846647B2 (en) | 2011-01-31 | 2014-09-30 | Bristol-Myers Squibb Company | C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity |
| JO3387B1 (ar) * | 2011-12-16 | 2019-03-13 | Glaxosmithkline Llc | مشتقات بيتولين |
-
2015
- 2015-11-12 US US15/524,298 patent/US9969767B2/en not_active Expired - Fee Related
- 2015-11-12 JP JP2017525933A patent/JP2017533937A/ja active Pending
- 2015-11-12 WO PCT/US2015/060344 patent/WO2016077561A1/en not_active Ceased
- 2015-11-12 KR KR1020177016222A patent/KR20170087478A/ko not_active Withdrawn
- 2015-11-12 RU RU2017118489A patent/RU2017118489A/ru not_active Application Discontinuation
- 2015-11-12 CA CA2967679A patent/CA2967679A1/en not_active Abandoned
- 2015-11-12 BR BR112017009850A patent/BR112017009850A2/pt not_active IP Right Cessation
- 2015-11-12 EP EP15798639.9A patent/EP3218387A1/en not_active Ceased
- 2015-11-12 AU AU2015346303A patent/AU2015346303B2/en not_active Ceased
- 2015-11-12 CN CN201580071098.2A patent/CN107250153A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011508748A (ja) * | 2008-01-03 | 2011-03-17 | バイロケム ファーマ インコーポレイテッド | 新規のルパン誘導体 |
| WO2011153315A1 (en) * | 2010-06-04 | 2011-12-08 | Bristol-Myers Squibb Company | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| WO2011153319A1 (en) * | 2010-06-04 | 2011-12-08 | Bristol-Myers Squibb Company | C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| JP2014507422A (ja) * | 2011-01-31 | 2014-03-27 | ブリストル−マイヤーズ スクイブ カンパニー | Ｈｉｖ成熟阻害剤としてのｃ−３修飾ベツリン酸誘導体のｃ−２８アミン |
| WO2013117137A1 (en) * | 2012-02-08 | 2013-08-15 | Jiangxi Qingfeng Pharmaceutical Inc. | Lupane triterpenoid derivatives and pharmaceutical use thereof |
| WO2013123019A1 (en) * | 2012-02-15 | 2013-08-22 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with hiv maturation inhibitory activity |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015346303B2 (en) | 2018-03-15 |
| BR112017009850A2 (pt) | 2018-01-16 |
| US20170334946A1 (en) | 2017-11-23 |
| RU2017118489A3 (enExample) | 2019-02-13 |
| CA2967679A1 (en) | 2016-05-19 |
| CN107250153A (zh) | 2017-10-13 |
| US9969767B2 (en) | 2018-05-15 |
| RU2017118489A (ru) | 2018-12-14 |
| KR20170087478A (ko) | 2017-07-28 |
| AU2015346303A1 (en) | 2017-06-08 |
| WO2016077561A1 (en) | 2016-05-19 |
| EP3218387A1 (en) | 2017-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5755731B2 (ja) | Ｈｉｖ成熟阻害剤としての修飾ｃ−３ベツリン酸誘導体のｃ−２８アミド | |
| JP6186012B2 (ja) | Ｃ−３アルキルおよびアルケニル修飾ベツリン酸誘導体 | |
| JP6155285B2 (ja) | Ｈｉｖ成熟阻害活性のあるｃ−３シクロアルケニルトリテルペノイド | |
| JP6212545B2 (ja) | Ｈｉｖ成熟阻害活性を有するｃ−１７二環式アミンのトリテルペノイド | |
| US10780102B2 (en) | Triterpenoids with HIV maturation inhibitory activity | |
| JP2013527242A (ja) | Ｈｉｖ成熟阻害剤としての修飾ｃ−３ベツリン酸誘導体 | |
| JP6735837B2 (ja) | Ｈｉｖ−１阻害剤としてのｃ−３およびｃ−１７修飾トリテルペノイド | |
| KR20150115881A (ko) | Hiv 성숙 억제 활성을 갖는 c-19 변형된 트리테르페노이드 | |
| JP2017533937A (ja) | オキソルペン誘導体 | |
| JP6620149B2 (ja) | 拡張ベツリン酸類似体 | |
| JP2017533934A (ja) | Ｃ１７アリール置換ベツリン酸類似体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180920 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180920 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191023 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200728 |